132 related articles for article (PubMed ID: 16075462)
1. Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11.
Chen CF; Yeh SH; Chen DS; Chen PJ; Jou YS
Genes Chromosomes Cancer; 2005 Nov; 44(3):320-8. PubMed ID: 16075462
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
Lin YW; Sheu JC; Liu LY; Chen CH; Lee HS; Huang GT; Wang JT; Lee PH; Lu FJ
Eur J Cancer; 1999 Nov; 35(12):1730-4. PubMed ID: 10674021
[TBL] [Abstract][Full Text] [Related]
3. [A preliminary report on two distinct tumor-suppressor regions on chromosome 1p36.2-p36.3 in human hepatocellular carcinomas].
Li H; Liew C; Ding M; Leow C; Wang X; Lau WJ; Wu S; Lee CK
Zhonghua Bing Li Xue Za Zhi; 1999 Jun; 28(3):197-200. PubMed ID: 11869529
[TBL] [Abstract][Full Text] [Related]
4. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
5. [Frequent loss of heterozygosity on chromosome 4 in human hepatocellular carcinoma].
Li X; Ding M; Lai B
Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):37-40. PubMed ID: 11798850
[TBL] [Abstract][Full Text] [Related]
6. Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis.
Cheng IK; Ching AK; Chan TC; Chan AW; Wong CK; Choy KW; Kwan M; Lai PB; Wong N
J Pathol; 2010 Feb; 220(3):348-60. PubMed ID: 19927314
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
[TBL] [Abstract][Full Text] [Related]
8. [A preliminary study of loss of heterozygosity on chromosome 1p in primary hepatocellular carcinoma].
Shao J; Li H; Liew CT; Wu Q; Liang X; Hou J
Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):28-30. PubMed ID: 11869508
[TBL] [Abstract][Full Text] [Related]
9. Frequent allelic loss on chromosome 9 in hepatocellular carcinoma.
Liew CT; Li HM; Lo KW; Leow CK; Lau WY; Hin LY; Lim BK; Lai PB; Chan JY; Wang XQ; Wu S; Lee JC
Int J Cancer; 1999 May; 81(3):319-24. PubMed ID: 10209942
[TBL] [Abstract][Full Text] [Related]
10. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
[TBL] [Abstract][Full Text] [Related]
11. Deletion mapping of chromosome 16q24 in hepatocellular carcinoma in Taiwan and mutational analysis of the 17-beta-HSD gene localized to the region.
Lin YW; Lee IN; Chen CH; Huang GT; Lee HS; Lee PH; Lu FJ; Sheu JC
Int J Cancer; 2001 Jul; 93(1):74-9. PubMed ID: 11391624
[TBL] [Abstract][Full Text] [Related]
12. [Cytogenetic and molecular genetic alterations on chromosome 4q in human hepatocellular carcinoma].
Zhang HK; Wang HY; Xia JC
Ai Zheng; 2008 Sep; 27(9):998-1005. PubMed ID: 18799044
[TBL] [Abstract][Full Text] [Related]
13. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
14. Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58% of liver cancer tissues from 60 Chinese patients, and four new homologs from other mammalians.
Chen J; Yu L; Li D; Gao Q; Wang J; Huang X; Bi G; Wu H; Zhao S
Gene; 2003 Jan; 302(1-2):103-13. PubMed ID: 12527201
[TBL] [Abstract][Full Text] [Related]
15. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.
Piao Z; Kim H; Jeon BK; Lee WJ; Park C
Cancer; 1997 Sep; 80(5):865-72. PubMed ID: 9307185
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of heterozygosity in two distinct regions, 8p23.1 and 8p22, in hepatocellular carcinoma.
Lu T; Hano H; Meng C; Nagatsuma K; Chiba S; Ikegami M
World J Gastroenterol; 2007 Feb; 13(7):1090-7. PubMed ID: 17373745
[TBL] [Abstract][Full Text] [Related]
18. Allelotype analysis of hepatocellular carcinoma.
Piao Z; Park C; Park JH; Kim H
Int J Cancer; 1998 Jan; 75(1):29-33. PubMed ID: 9426686
[TBL] [Abstract][Full Text] [Related]
19. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.
Zhao X; Li J; He Y; Lan F; Fu L; Guo J; Zhao R; Ye Y; He M; Chong W; Chen J; Zhang L; Yang N; Xu B; Wu M; Wan D; Gu J
Cancer Res; 2001 Oct; 61(20):7383-7. PubMed ID: 11606366
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on chromosome 10q22-10q23 and 22q11.2-22q12.1 and p53 gene in primary hepatocellular carcinoma.
Zhu GN; Zuo L; Zhou Q; Zhang SM; Zhu HQ; Gui SY; Wang Y
World J Gastroenterol; 2004 Jul; 10(13):1975-8. PubMed ID: 15222050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
